Consun Pharmaceutical Group Ltd (1681)

Hong Kong

Currency in HKD

1681 Pro Research

13.87

+0.17(+1.24%)

Closed·03:59:59

Fair Value

Unlock Value

Day's Range

13.57

13.88

52 wk Range

12.31

19.49

1681 Income Statement

Assess the Consun Pharma income statement, providing a detailed view of the company’s financial performance across activities. This statement outlines key financial figures such as revenue, expenses, operating income, and net income. Assess the 1681 net worth.

Period Ending:

2016

31/12

2017

31/12

2018

31/12

2019

31/12

2020

31/12

2021

31/12

2022

31/12

2023

31/12

2024

31/12

2025

31/12

Total Revenues

aa.aa

2,044.66

2,339.65

2,590.12

2,967.24

3,417.36

Total Revenues Growth

aa.aa

+16.65%

+14.43%

+10.71%

+14.56%

+15.17%

Cost Of Revenues

aa.aa

517.32

576.74

668.44

725.13

750.24

Gross Profit

aa.aa

1,527.34

1,762.91

1,921.68

2,242.1

2,667.12

Gross Profit Growth

aa.aa

+15.56%

+15.42%

+9.01%

+16.67%

+18.96%

Gross Profit Margin %

aa.aa

74.7%

75.35%

74.19%

75.56%

78.05%

Other Operating Expenses, Total

aa.aa

867.15

1,047.5

1,095.76

1,267.12

1,515.07

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	+12.39%	+20.8%	+4.61%	+15.64%	+19.57%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	881.95	1,061.97	1,155.21	1,284.67	1,517.39
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-14.8	-14.47	-59.45	-17.55	-2.32

Operating Income

aa.aa

660.18

715.41

825.92

974.99

1,152.05

Operating Income Growth

aa.aa

+20.01%

+8.37%

+15.45%

+18.05%

+18.16%

EBIT Margin %

aa.aa

32.29%

30.58%

31.89%

32.86%

33.71%

Net Interest Expenses

aa.aa

26.34

41.48

47.65

63.41

80.92

Net Interest Expenses Growth

aa.aa

+306.09%

+57.46%

+14.88%

+33.07%

+27.61%

Interest Expense, Total

aa.aa

-12.91

-10.93

-21.26

-24.89

-4.36

Interest And Investment Income

aa.aa

39.25

52.41

68.92

88.3

85.28

Other Non Operating Expenses, Total

aa.aa

11.33

-9.28

-9.03

-17.94

-34.62

EBT, Excl. Unusual Items

aa.aa

697.85

747.61

864.55

1,020.45

1,198.35

Gain (Loss) On Sale Of Assets

aa.aa

-1.99

-1.22

-0.85

-0.35

-1.93

Other Unusual Items, Total

aa.aa

EBT, Incl. Unusual Items

aa.aa

695.86

746.39

863.7

1,020.11

1,196.42

EBT, Incl. Unusual Items Growth

aa.aa

+19.21%

+7.26%

+15.72%

+18.11%

+17.28%

EBT, Incl. Unusual Items Margin

aa.aa

34.03%

31.9%

33.35%

34.38%

35.01%

Income Tax Expense

aa.aa

108.74

62.7

77.15

102.73

107.29

Net Income to Company

aa.aa

587.12

683.7

786.55

917.37

1,089.13

Minority Interest

aa.aa

3.06

-0.79

-2.02

-6.92

-11.07

Net Income

aa.aa

590.17

682.91

784.53

910.46

1,078.07

Net Income Growth

aa.aa

+18.32%

+15.71%

+14.88%

+16.05%

+18.41%

Net Income Margin %

aa.aa

28.86%

29.19%

30.29%

30.68%

31.55%

Preferred Dividend and Other Adjustments

aa.aa

Net Income to Common Excl. Extra Items

aa.aa

590.17

682.91

784.53

910.46

1,078.07

Basic EPS - Continuing Operations

aa.aa

0.74

0.86

0.99

1.11

1.27

Basic EPS - Continuing Operations Growth

aa.aa

+20.64%

+17.32%

+14.84%

+11.78%

+14.65%

Diluted EPS - Continuing Operations

aa.aa

0.73

0.86

0.98

1.09

1.26

Diluted EPS - Continuing Operations Growth

aa.aa

+19.67%

+17.81%

+13.95%

+11.22%

+15.6%

Basic Weighted Average Shares Outstanding

aa.aa

801.58

790.63

790.91

821.1

848.01

Diluted Weighted Average Shares Outstanding

aa.aa

804.7

792

799.17

832.11

855.13

Dividend Per Share

aa.aa

0.24

0.27

0.41

0.56

0.66

Dividend Per Share Growth

aa.aa

+3.66%

+8.58%

+53.93%

+38.03%

+16.35%

EBITDA

aa.aa

728.71

785.89

897.51

1,031.71

1,207.67

EBITDA Growth

aa.aa

+17.76%

+7.85%

+14.2%

+14.95%

+17.05%

EBITDA Margin %

aa.aa

35.64%

33.59%

34.65%

34.77%

35.34%

EBIT

aa.aa

660.18

715.41

825.92

974.99

1,152.05

* In Millions of CNY (except for per share items)

FAQ

What was Consun Pharma’s revenue at year end?

At the end of the last reported fiscal year, Consun Pharma (1681) recorded total revenue of 3,417.36 million CNY.

How much revenue did Consun Pharma report in the most recent quarter?

In its most recent quarterly earnings report, Consun Pharma posted revenue of 1,848.77 million CNY.

What was Consun Pharma’s net income for the year?

For the full year, Consun Pharma reported net income of 1,078.07 million CNY.

How much net income did Consun Pharma post in the last quarter?

In the most recent quarter, Consun Pharma (1681) posted net income of 579.77 million CNY.

What was Consun Pharma’s gross profit for the year?

Gross profit for the year was reported at 2,667.12 million CNY.

How much gross profit did Consun Pharma generate last quarter?

Consun Pharma recorded gross profit of 1,458.44 million CNY in its latest quarterly report.

What was Consun Pharma’s annual operating income?

For the full year, Consun Pharma (1681) reported operating income of 1,152.05 million CNY.

What was Consun Pharma’s operating income last quarter?

Quarterly operating income was 637.27 million CNY.

What was Consun Pharma’s quarterly EBITDA?

In the latest quarter, EBITDA was reported at 664.56 million CNY.

What was the quarter-over-quarter change in EBITDA for Consun Pharma?

EBITDA changed by 22.36% million CNY compared to the last quarter.

How did Consun Pharma’s revenue change compared to the previous quarter?

Revenue changed by 17.86% million CNY compared to the prior quarter.

What was the quarter-over-quarter change in gross profit for Consun Pharma?

In the latest quarter, gross profit changed by 20.66% million CNY from the previous quarter.

S&P/TSX

36,136.31

-10.11

-0.03%

S&P/TSX 60

2,131.87

+1.12

+0.05%

US 30

53,820.90

-64.3

-0.12%

US 500

7,705.00

-5.0

-0.06%

S&P 500 VIX

15.15

-0.66

-4.17%

DAX

26,140.13

+13.83

+0.05%

Dollar Index

99.855

+0.033

+0.03%

Market Movers

Name	Last	Chg. %	Vol.
Enbridge	72.40	-0.43%	13.08M
RBC	296.56	+0.21%	2.43M
Toronto Dominion Bank	169.97	+0.19%	3.68M
Shopify Inc	206.42	+2.20%	2.76M
Canadian Natural	63.83	+1.56%	8.23M
Bank of Montreal	253.46	+0.07%	1.97M
Suncor Energy	86.04	-2.36%	5.45M

Name	Last	Chg. %	Vol.
Aether Catalyst Solutions	0.01	+200.00%	53.50K
Green Scientific Labs Holdings	0.06	+120.00%	15.00K
Modern Meat Inc	0.130	+116.67%	1.08K
Digicann Ventures	0.010	+100.00%	2.00K
CardioComm Solutions Inc.	0.0100	+100.00%	25.00K
ePlay Digital	0.010	+100.00%	7.00K
James Bay Resources Ltd	0.020	+100.00%	1.47K

Name	Last	Chg. %	Vol.
Digital Asset Tech	0.01	-100.00%	200.00K
Lanebury Growth Capital	0.05	-68.75%	18.17K
Enablence Technologies	5.250	-58.82%	100.00
Noveris Health Sciences	0.445	-52.66%	72.73K
Noveris Health Sciences	0.45	-52.13%	1.95M
Molecule Holdings	0.005	-50.00%	20.11K
Kovo Healthtech	0.01	-50.00%	255.10K

Trending Stocks

Name	Last	Chg. %	Vol.
Celestica Inc.	442.65	-12.96%	781.44K
Canadian Natural	63.83	+1.56%	8.23M
BCE Inc	31.87	+3.27%	7.68M
TELUS	13.75	0.00%	12.44M
Hut 8	127.440	-1.87%	329.26K

Most Undervalued Stocks

Name	Last	Upside	Fair Value
Aaaaaaaaaaaaaaaa Aaa	104.02	+53.91%	160.10
Aa Aaaaaaa Aaaaa A	36.02	+52.24%	54.84
Aaaaaaa A Aaaaaaa A	5.26	+48.18%	7.79
Aaaaaaaaaa A	145.94	+44.47%	210.84
Aaaaaaaaaaaaaaa	17.38	+41.16%	24.53
A Aaaa	8.28	+40.80%	11.66
Aaaa Aaaaaaaaaaaaaa	11.70	+39.77%	16.35

Name	Last	Upside	Fair Value
Aaaaaaaaaaaaaaaa Aaa	104.02	+53.91%	160.10
Aa Aaaaaaa Aaaaa A	36.02	+52.24%	54.84
Aaaaaaa A Aaaaaaa A	5.26	+48.18%	7.79
Aaaaaaaaaa A	145.94	+44.47%	210.84
Aaaaaaaaaaaaaaa	17.38	+41.16%	24.53
A Aaaa	8.28	+40.80%	11.66
Aaaa Aaaaaaaaaaaaaa	11.70	+39.77%	16.35

See full list

Install Our AppScan QR code to install app

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Popular Searches

Please try another search

Consun Pharmaceutical Group Ltd (1681)

1681 Income Statement

FAQ

What was Consun Pharma’s revenue at year end?

How much revenue did Consun Pharma report in the most recent quarter?

What was Consun Pharma’s net income for the year?

How much net income did Consun Pharma post in the last quarter?

What was Consun Pharma’s gross profit for the year?

How much gross profit did Consun Pharma generate last quarter?

What was Consun Pharma’s annual operating income?

What was Consun Pharma’s operating income last quarter?

What was Consun Pharma’s quarterly EBITDA?

What was the quarter-over-quarter change in EBITDA for Consun Pharma?

How did Consun Pharma’s revenue change compared to the previous quarter?

What was the quarter-over-quarter change in gross profit for Consun Pharma?

Trending Stocks